Analyst Research and Recommendations: AutoWeb, Inc. (AUTO), Keryx Biopharmaceuticals, Inc. (KERX)

(NASDAQ:KERX) have been given a consensus rating of "Hold" by the fourteen research firms that are now covering the company.

Analysts have given a mean recommendation of 2.40 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Ameritas Investment invested in 6,152 shares or 0% of the stock. Keryx Biopharmaceuticals now has an average rating of "Hold" and a consensus price target of $7.48. Zacks Investment Research cut Keryx Biopharmaceuticals from a "buy" rating to a "hold" rating in a report on Wednesday, August 3rd. In a report issued on September 12, Raymond James analyst Reni Benjamin maintained a Buy rating on KERX, with a price target of $9, which implies an upside of 44% from current levels. The rating was downgraded by Brean Capital to "Hold" on Tuesday, August 2.

A number of institutional investors have recently modified their holdings of KERX.

In the wake of the FDA approval, Keryx shares are falling almost 12% to $5.50.

Currently Keryx Biopharm Inc (NASDAQ:KERX)'s shares owned by insiders are 0.9%, whereas shares owned by institutional owners are 67.7%.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) ended its day at $6.37 with the rising stream of 10.78% and its total traded volume was 3.92 million shares more than the average volume. BlackRock Group LTD raised its position in shares of Keryx Biopharmaceuticals by 5.0% in the third quarter. Legal & General Group Plc now owns 25,985 shares of the biopharmaceutical company's stock worth $161,000 after purchasing an additional 300 shares in the last quarter. BlackRock Advisors LLC now owns 45,653 shares of the biopharmaceutical company's stock valued at $242,000 after buying an additional 2,413 shares during the period. Finally, Legal & General Group Plc increased its holdings in Keryx Biopharmaceuticals by 1.2% during the 1st quarter.

This article was originally published by and is the sole property of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of USA and worldwide trademark & copyright legislation.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), at its latest closing price of $6.37, it has a price-to-book ratio of 29.43, compared to an industry average at 20.78. However the company reported $-0.39 earnings per share for the same quarter during previous year. The company has a 50 day moving average of $5.19 and a 200 day moving average of $5.48. The company has market cap of $619.88 million. The stock volatility for the week was 8.60% while for the month was 7.08%.

Keryx Biopharmaceuticals Inc. (KERX) has the market capitalization of $667.79 Million. Keryx Biopharmaceuticals, Inc. has 107.19 million shares outstand ing, and in the last trade has seen ATR around 0.43.

Looking forward, the company's quarterly earnings are expected to come at $0.44 in the three months through December 2017 and $0.51 in the quarter ending March 2018, reflecting -2.22% and 8.51% growth, respectively.

Keryx Biopharmaceuticals, a biopharmaceutical firm focused on the development of medicines for people with renal disease. Revenue during the quarter was $15.14 million, representing 63% growth from $9.29 million in year-ago quarter. The 1 year EPS growth rate is -28.40%. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

Like this


08 November 2017
Callon Petroleum Company (CPE) Posts Earnings Results
The South Carolina-based Greenwood Capital Associates Limited Liability has invested 0.09% in Callon Petroleum Company (NYSE:CPE). Cardinal Mngmt Ltd Ct invested in 4.26 million shares or 1.79% of the stock. 33 funds opened positions while 128 raised stakes.

07 November 2017
Texas gunman had violent past
But for Lepp, the pain the small town of Sutherland Springs is going through is something he feels even from far away. Former classmate Nina Rose Vaca told the Dallas Morning News: "He was a little unusual but it was high school".

07 November 2017
UBS Asset Management Americas Inc. Cuts Holdings in Pacira Pharmaceuticals, Inc. (PCRX)
It dropped, as 67 investors sold CTL shares while 185 reduced holdings. 123 funds opened positions while 564 raised stakes. Cowen and Company restated a "hold" rating on shares of Pacira Pharmaceuticals in a report on Tuesday, September 20th.

07 November 2017
Google Assistant comes to Sony TVs
Sony bears no responsibility in the event that services offered by third parties are changed, disrupted, suspended or terminated. Starting today, Google Assistant on Android and iOS will be able to send you daily weather updates, quotes, and more.

07 November 2017
Trump administration to allow states to impose work requirements on Medicaid recipients
About 59 percent of nondisabled adults on Medicaid who are under 65 years old have jobs, the organization found. Verma suggested work requirements were an appropriate response to the expanded Medicaid population.

07 November 2017
Tokyo Hopes to Solidify Cooperation with Washington
The moment happened as Trump and Japanese Prime Minister Shinzo Abe headed to lunch. "The relationship is really extraordinary. President Donald Trump speaks at a news conference at the presidential Blue House in Seoul, South Korea, on November 7, 2017.

07 November 2017
Shot Near USC Upstate, Police Searching Campus for Suspect
The suspect is a black male, said to be wearing khaki trousers and a grey hoodie; he is also believed to be carrying a weapon. There is said to be an active shooter situation near the University of SC , with one person believed to have been shot.

07 November 2017
Demonetisation not one-off solution, but changed black money agenda: Arun Jaitley
During the UPA (tenure), there was policy paralysis, while structural reforms have been initiated during NDA", Jaitley added. The Finance Minister said that overall, demonetisation has created a "cleaner, transparent and honest financial system".

07 November 2017
New Trailer For Sherlock Gnomes Focuses On Johnny Depp's Character
Paramount Pictures has released the first trailer for the upcoming animated film Sherlock Gnomes , and it's, well, something. Here's a synopsis: The beloved garden gnomes from Gnomeo and Juliet are back for a whole new adventure in London.

07 November 2017
Revenue Approximations Analysis: Abraxas Petroleum Corporation (AXAS), Marsh & McLennan Companies, Inc. (MMC)
In the past few sessions, investors have started paying a little bit more attention to shares of Marsh & McLennan Companies, Inc. Cubist Systematic Strategies Ltd Liability Com holds 0.07% of its portfolio in Marsh & McLennan Companies, Inc. (NYSE:MMC).